Default: Current Pharmaceutical Design

ISSN: 1381-6128

Journal Home

Journal Guideline

Current Pharmaceutical Design Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Pharmaceutical Design is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 159. It has an SJR impact factor of 0,69 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,69.

Current Pharmaceutical Design focuses its scope in these topics and keywords: current, systematic, interaction, inhibitorsphosphodiesterase, inhibitors, impact, future, fatty, essential, kinase, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Current Pharmaceutical Design

0,69

SJR Impact factor

159

H Index

515

Total Docs (Last Year)

1637

Total Docs (3 years)

53205

Total Refs

4737

Total Cites (3 years)

1517

Citable Docs (3 years)

2,63

Cites/Doc (2 years)

103,31

Ref/Doc

Aims and Scope


current, systematic, interaction, inhibitorsphosphodiesterase, inhibitors, impact, future, fatty, essential, kinase, lead, management, metabolism, mini, modeling, nervous, oils, omega, overview, erectile, ellagic, effects, activities, adaptive, reviewstrategies, antifolates, antioxidant, applications, arterial, atherosclerosis, complexed, components, cyclodextrins, design, directions, discoveryinsights, drug, dysfunction,



Best articles by citations

Copper and Neurotoxicity in Autism Spectrum Disorder

View more

microRNAs in Autism Spectrum Disorders

View more

Gut-liver Axis and Microbiota in NAFLD: Insight Pathophysiology for Novel Therapeutic Target

View more

Endothelial Chemokines in Autoimmune Disease

View more

New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives

View more

Vitex Diterpenoids: Structural Diversity and Pharmacological Activity

View more

Current Options for the Pharmacotherapy of Obesity

View more

Current Trends in Vascular Biology and Atherothrombosis

View more

Diabetes and Vascular Disease: Is It All About Glycemia?

View more

The Effects of Quercetin Supplementation on Blood Pressures and Endothelial Function Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials

View more

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers

View more

Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases

View more
SHOW MORE ARTICLES

Potential of Gentiana lutea for the Treatment of Obesity-associated Diseases

View more

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

View more

Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases

View more

Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component

View more

Effects of IGF-1 on the Cardiovascular System

View more

Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review

View more

Basic Cell Biology of Trypanosoma cruzi

View more

The Plastid-Like Organelle of Apicomplexan Parasites as Drug Target

View more

Adjunctive Immunotherapy of Mycobacterial Infections

View more

Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS

View more

Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations

View more

Role of Dietary Fiber and Short-Chain Fatty Acids in the Colon

View more

Comments

No comments ... Be the first to comment!

FAQS